Wenlang Fu
Merck & Co., Inc., Rahway, NJ, USA (United States)(US)
Publications by Year
Research Areas
RNA Interference and Gene Delivery, Advanced biosensing and bioanalysis techniques, Cytomegalovirus and herpesvirus research, Adenosine and Purinergic Signaling, MicroRNA in disease regulation
Most-Cited Works
- → Quinazolinone Derivatives as Orally Available Ghrelin Receptor Antagonists for the Treatment of Diabetes and Obesity(2007)157 cited
- → siRNA-optimized Modifications for Enhanced In Vivo Activity(2012)89 cited
- → Cyclic‐Disulfide‐Based Prodrugs for Cytosol‐Specific Drug Delivery(2014)24 cited
- → Nucleoside Optimization for RNAi: A High-Throughput Platform(2011)16 cited
- Pyrrolotriazine derivatives useful for treating hyperproliferative disorders and diseases associated with angiogenesis(2007)